Algernon NeuroScience and the Centre for Human Drug
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT:...
Source: globenewswire.com
Rick Strassman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rick Strassman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rick Strassman Today - Breaking & Trending Today
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More - Awakn Life Sciences (OTC:AWKNF), ATAI Life Sciences (NASDAQ:ATAI)
President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also contains a mandate to fund clinical trials with psychedelics for active service members.
Source: benzinga.com
Move Over, New York Times Bestseller List. Joe Rogan Is the New Kingmaker for Authors
While many of Rogan's authors will never see their name in The New York Review of Books, they and their publishers don't need those institutions anymore.
Source: newsweek.com
Ayahuasca and DMT: A Portal into the Universal Mind
Explore the historical tapestry of Ayahuasca and DMT across civilizations and their transformative power. Discover Ayahuasca retreats for spiritual exploration and personal growth.
Source: thecostaricanews.com
Algernon NeuroScience Announces 40 Patient Phase 2 Psychedelic Drug DMT Stroke Study
VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), has completed a feasibility study and has finalized its clinical trial design for a 40 patient Phase 2 DMT Stroke study. AGN Neuro is the world’s first company to investigate DMT for the tre
Source: yahoo.com